Hutson Nancy J
Director at BCRX; Director at Endo International plc; Director at CUBIST PHARMACEUTICALS INC
- Sold, on record
- $4.4M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Dec 13, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- BCRXBIOCRYST PHARMACEUTICALS INCDirector
- Endo International plcDirector
- CUBIST PHARMACEUTICALS INCDirector
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- BCRX148,199 shares
- CUBIST PHARMACEUTICALS INC29,000 shares
- Endo International plc23,738 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Endo International plcPlan not statedMar 9, 2017 2017
Sold 5,325 shares at $10.82 ($58k)
Hutson Nancy J, Director
Sold 14.6% of holdings ($396k position)31,252 shares leftFiling
- 2 Form 4 sale Endo International plcPlan not statedNov 15, 2018 +616 days
Sold 10,000 shares at $12.83 ($128k)
Hutson Nancy J, Director
Sold 16.7% of holdings ($769k position)49,970 shares leftFiling
- 3 Form 4 sale BCRXUnusualJun 10, 2021 +938 days
Sold 23,333 shares at $16.86 ($393k)
Hutson Nancy J, Director
Sold 26.4% of holdings ($1.5M position)65,073 shares leftFirst sale on recordFiling
- 4 Form 4 sale BCRXUnusualOct 15, 2021 +127 days
Sold 105,000 shares at $15.40 ($1.6M)
Hutson Nancy J, Director
Sold 61.7% of holdings ($2.6M position)65,073 shares leftFiling
- 5 Form 144 notice BCRXNoticeJun 14, 2023 +607 days
Filed to sell 12,866 shares ($104k)
Hutson Nancy J, Officer
No 10b5-1 planFiling
- 6 Form 4 sale BCRXNo planJun 14, 2023 same day
Sold 12,866 shares at $8.04 ($103k)
Hutson Nancy J, Director
No 10b5-1 planSold 13.6% of holdings ($761k position)81,818 shares leftFollows a Form 144Filing
- 7 Form 144 notice BCRXNoticeDec 13, 2024 +548 days
Filed to sell 7,000 shares ($53k)
Hutson Nancy J, Director
10b5-1 planFirst sale on recordFiling
- 8 Form 4 sale BCRXRoutineDec 13, 2024 same day
Sold 7,000 shares at $7.54 ($53k)
Hutson Nancy J, Director
10b5-1 planSold 7.5% of holdings ($706k position)86,638 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (15)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | Dec 16, 2024 | BCRX | Director | Form 4 sale | 7,000 | $53k | 7.5% | Routine | SEC |
| Dec 13, 2024 | Dec 13, 2024 | BCRX | Director | Form 144 notice | 7,000 | $53k | Notice | SEC | |
| Jun 14, 2023 | Jun 15, 2023 | BCRX | Director | Form 4 sale | 12,866 | $103k | 13.6% | No plan | SEC |
| Jun 14, 2023 | Jun 14, 2023 | BCRX | Officer | Form 144 notice | 12,866 | $104k | Notice | SEC | |
| Oct 15, 2021 | Oct 19, 2021 | BCRX | Director | Form 4 sale | 105,000 | $1.6M | 61.7% | Unusual | SEC |
| Jun 10, 2021 | Jun 14, 2021 | BCRX | Director | Form 4 sale | 23,333 | $393k | 26.4% | Unusual | SEC |
| Nov 15, 2018 | Nov 16, 2018 | Endo International plc | Director | Form 4 sale | 10,000 | $128k | 16.7% | Plan not stated | SEC |
| Mar 9, 2017 | Mar 10, 2017 | Endo International plc | Director | Form 4 sale | 5,325 | $58k | 14.6% | Plan not stated | SEC |
| Mar 1, 2016 | Mar 3, 2016 | Endo International plc | Director | Form 4 sale | 3,413 | $144k | 8.5% | Plan not stated | SEC |
| Aug 18, 2014 | Aug 18, 2014 | CUBIST PHARMACEUTICALS INC | Director | Form 4 sale | 9,000 | $585k | 60.2% | Unusual | SEC |
| Mar 10, 2014 | Mar 11, 2014 | Endo International plc | Director | Form 4 sale | 5,000 | $361k | 19.6% | Plan not stated | SEC |
| Jul 26, 2013 | Jul 29, 2013 | CUBIST PHARMACEUTICALS INC | Director | Form 4 sale | 5,000 | $269k | 50.8% | Unusual | SEC |
| Apr 26, 2013 | Apr 26, 2013 | CUBIST PHARMACEUTICALS INC | Director | Form 4 sale | 5,000 | $231k | 58.8% | Unusual | SEC |
| Jan 28, 2013 | Jan 30, 2013 | CUBIST PHARMACEUTICALS INC | Director | Form 4 sale | 5,000 | $216k | 58.8% | Unusual | SEC |
| Oct 26, 2012 | Oct 30, 2012 | CUBIST PHARMACEUTICALS INC | Director | Form 4 sale | 5,000 | $218k | 58.8% | Unusual | SEC |